Detalles de la búsqueda
1.
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma.
J Transl Med
; 20(1): 159, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35382857
2.
The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates.
BMC Cancer
; 21(1): 8, 2021 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33402122
3.
Melanoma: the new perspectives from clinical and translational research.
Anticancer Drugs
; 30(6): 543-553, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31021826
4.
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.
J Am Acad Dermatol
; 80(1): 99-105.e5, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30447951
5.
MicroRNAs role as potential biomarkers and key regulators in melanoma.
Genes Chromosomes Cancer
; 56(1): 3-10, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27561079
6.
Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases.
J Am Acad Dermatol
; 76(2): 264-273.e2, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27847125
7.
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.
Eur J Cancer
; 199: 113542, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38266540
8.
Patients with cancer and hospital admissions: disease trajectory and strategic choices.
BMJ Support Palliat Care
; 2023 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37704262
9.
The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study.
Cancers (Basel)
; 15(12)2023 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37370816
10.
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Eur J Cancer
; 187: 25-35, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099946
11.
How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review.
Biomedicines
; 10(8)2022 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36009369
12.
Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score.
Support Care Cancer
; 19(11): 1823-30, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21560032
13.
Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review.
Eur J Case Rep Intern Med
; 8(7): 002639, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34268267
14.
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study.
Cancers (Basel)
; 13(3)2021 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33530579
15.
Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience.
Front Oncol
; 11: 672797, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34307142
16.
Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy.
Tumori
; 106(5): 427-431, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32703089
17.
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study.
J Geriatr Oncol
; 11(3): 515-522, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31928943
18.
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival.
Front Oncol
; 10: 1652, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33042809
19.
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors.
J Immunother Cancer
; 7(1): 308, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31730502
20.
Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.
Clin Cancer Res
; 13(14): 4061-8, 2007 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17634530